Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices
Phase 4
- Conditions
- Diabetes Type II
- Interventions
- Device: V-Go
- First Posted Date
- 2015-02-11
- Last Posted Date
- 2015-02-11
- Lead Sponsor
- Valeritas, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT02361489
- Locations
- 🇺🇸
Geisinger, Wilkes Barre, Pennsylvania, United States
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Device: V-Go™
- First Posted Date
- 2011-03-31
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- Valeritas, Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT01326598
- Locations
- 🇺🇸
PMG Research of Knoxville, Knoxville, Tennessee, United States
🇺🇸Alan B. Schorr, DO FACE, Langhorne, Pennsylvania, United States
🇺🇸San Diego Coastal Endocrinology Group, Chula Vista, California, United States
Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device
Phase 4
Terminated
- Conditions
- Type 1 DiabetesType 2 Diabetes
- First Posted Date
- 2007-03-29
- Last Posted Date
- 2007-12-06
- Lead Sponsor
- Valeritas, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00453934
- Locations
- 🇺🇸
Diabetes and Glandular Research, San Antonio, Texas, United States